ARCHIVES

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

January 26, 2001

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

Maryland Contract Leafs New FY Awards

July 25, 1975

Two Phase III Trials Show Increase In PFS In Two Distinct Patient Populations

June 28, 2013

NCI Programs: Colorectal Cancer Progress Review Group To Assess Research

October 1, 1999

Switch To NTP Holds Down Entry Of New Compounds; Obey Supports NCI On Need For More Positions

March 16, 1979